EXPRESSION VON NEUROPEPTIDEN
European patent · EP3703716 · In force
Register entry
- Publication number
- EP3703716
- Application number
- EP18873220
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 1, 2018
- Published
- Sep 9, 2020
- Granted
- Mar 25, 2026
- Protection ends at the latest
- Oct 31, 2038
- Next annual fee due
- Nov 30, 2026
- IPC classes
- A61K 35/30 (2015.01)A61K 48/00 (2006.01)
- Priority
- US 201762580846 P 02.11.2017
- PCT application
- PCT/US2018/058808 01.11.2018
- PCT publication
- WO2019/090000 09.05.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 25, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.03.2026
Parties
Holder
Inventor
ANDERSON, David, J.
Altadena California 91001, US
ZELIKOWSKY, Moriel
Pasadena California 91125, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.